Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 357

1.

Hematopoietic growth factors in myelodysplastic syndromes.

Blinder VS, Roboz GJ.

Curr Hematol Rep. 2003 Nov;2(6):453-8. Review.

PMID:
14561388
2.

Hematopoietic growth factors in the treatment of the myelodysplastic syndromes.

Ganser A.

Curr Opin Hematol. 1995 May;2(3):204-9. Review.

PMID:
9371996
3.
4.

Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study.

Balleari E, Rossi E, Clavio M, Congiu A, Gobbi M, Grosso M, Secondo V, Spriano M, Timitilli S, Ghio R.

Ann Hematol. 2006 Mar;85(3):174-80. Epub 2006 Jan 12.

PMID:
16408206
5.

Hematopoietic growth factors in the treatment of acquired bone marrow failure states.

Marsh JC, Ganser A, Stadler M.

Semin Hematol. 2007 Jul;44(3):138-47. Review.

PMID:
17631178
6.

Role of hematopoietic growth factors in transfusion medicine.

Goodnough LT.

Curr Opin Hematol. 1994 Nov;1(6):462-70. Review.

PMID:
9371324
7.

Treatment of anaemia in myelodysplastic syndromes with prolonged administration of recombinant human granulocyte colony-stimulating factor and erythropoietin.

Mantovani L, Lentini G, Hentschel B, Wickramanayake PD, Loeffler M, Diehl V, Tesch H.

Br J Haematol. 2000 May;109(2):367-75.

PMID:
10848827
8.

Haemopoietic growth factors in myelodysplastic syndromes: towards patient-oriented therapy?

Clavio M, Balleari E, Garrone A, Ballerini F, Varaldo R, Michelis GL, Balocco M, Abdall N, Colombo N, Grasso R, Gobbi M.

J Exp Clin Cancer Res. 2005 Mar;24(1):5-16. Review.

PMID:
15943026
9.
10.

Treatment of myelodysplastic syndromes with hematopoietic growth factors.

Ganser A, Hoelzer D.

Hematol Oncol Clin North Am. 1992 Jun;6(3):633-53. Review.

PMID:
1377194
11.

Supportive care and use of hematopoietic growth factors in myelodysplastic syndromes.

Hellström-Lindberg E, Malcovati L.

Semin Hematol. 2008 Jan;45(1):14-22. doi: 10.1053/j.seminhematol.2007.10.004. Review.

PMID:
18179965
12.

The role of rHuEpo in low-risk myelodysplastic syndrome patients.

Rigolin GM, Castoldi G.

Leuk Lymphoma. 2005 Jun;46(6):823-31. Review.

PMID:
16019526
13.

Hematopoietic growth factors in cancer chemotherapy.

Lieschke GJ, Foote M, Morstyn G.

Cancer Chemother Biol Response Modif. 1997;17:363-89. Review. No abstract available.

PMID:
9551221
14.

[Current status of the clinical application of hematopoietic growth factors in oncology].

Karthaus M, Ganser A.

Ther Umsch. 1996 Nov;53(11):863-73. Review. German.

PMID:
8984692
15.

Alternatives to conventional or myeloablative chemotherapy in myelodysplastic syndrome.

Cazzola M.

Int J Hematol. 2000 Aug;72(2):134-8. Review.

PMID:
11039660
16.

The role of hematopoietic growth factors in the treatment of neoplastic diseases.

St Onge J, Jacobson RJ.

Semin Hematol. 1992 Jul;29(3 Suppl 2):53-63. Review. No abstract available.

PMID:
1380737
17.

Supportive care including growth factors in myelodysplastic syndromes.

Gardin C, Fenaux P.

Rev Clin Exp Hematol. 2004 Dec 1;8(2):E3. Review.

PMID:
16027101
18.

Emerging therapeutic and supportive care approaches for the myelodisplastic syndromes.

Mufti GJ.

Rev Clin Exp Hematol. 2004 Dec 1;8(2):E4. Review. No abstract available.

PMID:
16027102
19.
20.

The role of haematopoietic growth factors in the treatment of myelodysplastic syndromes.

Rossi Ferrini P, Santini V, Ciolli S, Grossi A, Leoni F, Rafanelli D, Vannucchi AM.

Hematol Oncol. 1993;11 Suppl 1:32-5. Review. No abstract available.

PMID:
7683622

Supplemental Content

Support Center